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The Unfolded Protein Response Modulates
Disease Severity in Pelizaeus-Merzbacher Disease
an X-linked recessive pediatric disorder characterized
by three common genetic forms of disease: coding re-
gion or splice site mutations, duplications of the wild-
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type PLP1 gene, and null alleles. These mutations yield2 Department of Pediatrics
a broad spectrum of disease phenotypes from severe,3 Department of Neurology
connatal disease to mild forms characterized by pureWayne State University School of Medicine
spastic paraparesis (reviewed in Garbern et al., 1999;Detroit, Michigan 48201
Southwood and Gow, 2001). Mutant alleles that model
all three of these genetic forms of PMD are available in
mice, including (1) myelin synthesis-deficient (msd), anSummary
A242V missense mutation causing severe disease, also
identified in patients (Gencic and Hudson, 1990; Yama-The unfolded protein response (UPR) is a eukaryotic
moto et al., 1998) and rumpshaker (rsh), an I186T mis-signaling pathway linking protein flux through the en-
sense mutation causing mild disease, also found in pa-doplasmic reticulum to transcription and translational
tients (Kobayashi et al., 1994; Schneider et al., 1992);repression. Herein, we demonstrate UPR activation
(2) 4e-Plp, comprising supernumerary copies of a 40 kbin the leukodystrophy Pelizaeus-Merzbacher disease
wild-type Plp1 transgene causing overexpression (Ka-(PMD) as well as in three mouse models of this disease
gawa et al., 1994); and (3) Plp1 null (Klugmann et al.,and transfected fibroblasts expressing mutant protein.
1997; Rosenbluth et al., 1996; Stecca et al., 2000). Dis-The CHOP protein, widely known as a proapoptotic
ease in msd mice is apparent by 12 days postnatal (P12)transcription factor, modulates pathogenesis in the
as moderate tremors, which rapidly progress throughmouse models of PMD; however, this protein exhibits
severe tremors to seizures causing death by 3–4 weeks.antiapoptotic activity. Together, these data show that
On the other hand, rsh mice develop symptoms by P14–the UPR has the potential to modulate disease severity
16, exhibit moderate tremors and ataxia, but rarely ex-in many cells expressing mutant secretory pathway
hibit seizures and have a normal life span (Fanarraga etproteins. Thus, PMD represents the first member of
al., 1992; Griffiths et al., 1990). Disease severity causeda novel class of disparate degenerative diseases for
by PLP1 gene duplication is proportional to the degreewhich UPR activation and signaling is the common
of overexpression (Ikenaka and Kagawa, 1995), and nullpathogenic mechanism.
alleles cause mild disease.
Molecular mechanisms underlying the phenotypes ofIntroduction
most PLP1 mutations are virtually unknown. Morpholog-
ical analyses of oligodendrocytes from animal modelsOf the myriad physiological processes ongoing in all
indicate that distinct cellular defects underlie pathogen-living organisms, few are more important to survival at
esis of different genetic forms of PMD. For example,the levels of the cell and the organism than adaptation
several missense mutations perturb endoplasmic reticu-to stress. Primordial lifeforms contended with ever
lum ultrastructure (Duncan, 1990); PLP1 overexpressionchanging environmental conditions by rapid changes at
causes swelling of the Golgi apparatus and aberrantthe transcriptional and posttranscriptional levels, and
cholesterol trafficking (Kagawa et al., 1994; Readheadsince that time, virtually all species have retained and
et al., 1994; Simons et al., 2002); and null alleles causeexpanded such rudimentary signaling cascades to sus-
axonal abnormalities with late Wallerian degeneration
tain life under adverse conditions. The unfolded protein
and oligodendrocyte loss (Griffiths et al., 1998; Stecca
response (UPR) is a stress-induced signaling cascade
et al., 2000).
in eukaryotes, and recent appreciation of its importance Herein, we investigate involvement of the UPR in
as a central regulatory circuit in the secretory pathway pathogenesis arising from PLP1 coding region muta-
has prompted broad interest in consequences to cells tions and demonstrate that several mutations activate
should the UPR be disrupted or overwhelmed (Travers this signaling cascade. CHOP is induced in and localized
et al., 2000). Indeed, correlative evidence implicates the to the nuclei of transfected fibroblasts expressing mu-
UPR in a number of genetic diseases (Aridor and Balch, tant PLP1, cultured oligodendrocytes from msd mice,
1999). For example, mutations in the PRESENILIN gene and oligodendrocytes from rsh and msd mice express-
from familial Alzheimer patients cause abnormal IRE1 ing mutant Plp1 gene products in vivo. Moreover, we
processing (Katayama et al., 1999; Niwa et al., 1999). show by Northern blotting and immunocytochemistry
In this instance, the molecular defect alone does not that CHOP is induced in oligodendrocytes from a PMD
compromise UPR induction (Sato et al., 2000) but, con- patient harboring a splice site mutation that excludes
ceivably, may sensitize neurons to other insults. exon 6 from PLP1 gene products. Finally, we directly
We have investigated molecular pathogenesis of the demonstrate that CHOP modulates disease severity in
leukodystrophy Pelizaeus-Merzbacher disease (PMD), rsh mice and normally serves to protect oligodendro-
a neurodegenerative disease causing diffuse hypomy- cytes from apoptosis. Together, these data provide
elination of the central nervous system (CNS). PMD is compelling evidence that the UPR is relevant to patho-
genesis in PMD, thereby attesting to the importance
of this regulatory pathway in disease. More broadly,4 Correspondence: agow@genetics.wayne.edu
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suppositions by others that mutant secretory pathway
proteins cause disease in different cell types through
activation of the UPR portends PMD as the first example
of a novel class of disparate degenerative diseases that
nevertheless arise from a common molecular mech-
anism.
Results
The UPR has been examined in yeast and cultured mam-
malian cells following induction by noxious stimuli such
as tunicamycin to inhibit glycoprotein synthesis, thapsi-
gargin to mobilize internal Ca2 stores and expression
of mutant secretory pathway proteins that accumulate
in the endoplasmic reticulum (ER). Currently, the UPR
is known to be activated through posttranslational pro-
cessing of three ER-resident proteins, the Ire1 and PERK
receptor kinases and the membrane-tethered transcrip-
tion factor ATF6. These initiating proteins regulate trans-
lation of mRNAs encoding the XBP-1 and ATF-4 tran-
scription factors and the expression of effector genes,
including molecular chaperones and additional tran-
scription factors such as CHOP and ATF3 (reviewed in
Ma and Hendershot, 2001; Zinszner et al., 1998). Given
the complexity of the UPR and our incomplete knowl-
edge of this signaling cascade, we contend that the
most reliable reporters of a UPR “in progress” are the
effector molecules. In this regard, CHOP is downstream
of PERK, BiP is downstream of Ire1, while Erp59 and
Erp72 are downstream of ATF6 (Harding et al., 2000; Ma
et al., 2002; Okada et al., 2002).
CHOP Is Expressed in Fibroblasts Transfected
with Mutant PLP1 Constructs
To determine if the UPR is induced in vitro by mutant
forms of PLP1 gene products, we transiently transfected
COS-7 cells with plasmids encoding either wild-type
PLP1 or the missense mutant from msd mice (PLP1msd).
Figure 1. The UPR Is Induced in Cells Expressing Mutant PLP1At 24 hr, essentially all transfected cells expressing
(A) Transfected COS-7 cells expressing mutant (Aa) but not wild-PLP1msd localize this protein in the ER (green staining in
type (Ab) PLP1 (green) localize CHOP (red) in the nucleus (blue).Figure 1Aa) as demonstrated previously (Gow et al.,
Arrowheads show CHOP cells (pink/white nuclei). Scale bar, 20m.
1994a, 1994b). Most transfected cells also express (B) Morphometry of transfected COS-7 cells showing transfection
CHOP (white/pink staining, arrowheads), which colocal- efficiency (bars i and iv) and PLP1/CHOP cells expressed as a
izes with the nuclear stain DAPI (blue). In contrast, the proportion of transfected (ii and v ) or stressed (iii and vi) cells.
(C) Northern blots show induction of UPR effector genes in 293Toverwhelming majority of nontransfected cells are
cells untreated (NT), treated with tunicamycin (Tunic), or transfectedCHOP negative, indicating that the experimental proce-
with wild-type or mutant PLP1.dure alone does not induce this gene. Transfected cells
(D) Oligodendrocyte progenitors from wild-type mice (Da) elaborate
that express wild-type PLP1 transport this protein to cell processes, differentiate, and incorporate Plp1 gene products
all major compartments of the secretory and endocytic into the plasma membrane (green). Progenitors from msd mice also
pathways (arrows), as shown previously (Gow et al., extend processes, which are subsequently resorbed (arrows) after
the cells differentiate and express the Plp1 gene (Db). These cells1994a), but the vast majority of these cells are CHOP
localize CHOP (red) in the nucleus which appears as yellow/orangenegative (Figure 1Ab).
(arrowheads). Scale bar, 10 m.Cell counts demonstrate that CHOP expression
strongly correlates with the expression of mutant but
not wild-type PLP1. Transfected cells (n  200) labeled labeled cells (PLP1/CHOP) as a proportion of trans-
fected cells (PLP1). Only 10% of cells expressing wild-with antibodies against PLP1 and CHOP in duplicate
plates from two independent experiments are character- type PLP1 also express CHOP; however, 70% of cells
expressing PLP1msd also express CHOP. Third, bars iiiized in Figure 1B using several criteria. First, transfected
cells are represented as a proportion of total cells (white and vi show that most CHOP-positive cells express
PLP1 (85%), which indicates that transfection condi-bars i and iv). This transfection efficiency is similar for
PLP1 and PLP1msd expressing cells (20%) and rules tions alone do not induce CHOP expression. Consistent
with this finding, few cells from cultures transfectedout significant contributions from differences in plasmid
toxicity. Second, dark bars (ii and v ) represent double- without plasmid DNA or with an empty expression plas-
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mid express CHOP (1.5%–4%). On the other hand, 93% dramatically during the postnatal period, beginning at
P7 and corresponding with the age that we detect Plp1of untransfected cells treated with 2 g/ml of tuni-
camycin for 4 hr are strongly labeled by anti-CHOP anti- expression. Chop expression is maximal between
P16–18 and decreases by P21, near the age of death.bodies. Together, these data clearly indicate that the
UPR is activated by inhibiting N-glycosylation and by This decline may be related to depletion of the oligoden-
drocyte lineage similar to that reported for the allelicexpressing mutant forms of PLP1 that accumulate in
the ER. jimpy (jp) mouse (Knapp et al., 1986), which harbors
a splice site mutation causing exon 5 skipping and aFrom Northern blots, we find that several UPR effector
genes are induced in tunicamycin-treated and PLP1msd- frameshift in the remaining coding region (Hudson et
al., 1987). Although Chop is weakly expressed in con-expressing 293T cells (Figure 1C). Steady-state levels
of mRNAs encoding the transcription factors Chop and trols, the level is constant with age and indicates that
induction of this gene is not a feature of normal CNSAtf3 as well as the molecular chaperones BiP, Erp72,
and possibly Erp59 are induced in these cells compared development. Similar results for Plp1 and Chop are ob-
served in msd brains.to controls. Together, these data reflect activation of
Ire1, PERK, and ATF6. On the other hand, the level of In Figure 1C, we observe that mRNA encoding a sec-
ond bZip transcription factor, ATF3, is induced in 293Tactivation of downstream target genes differs between
tunicamycin-treated and PLP1msd-expressing cells. For cells expressing mutant PLP1. Atf3 is also strongly in-
duced in spinal cords of msd mice, although the timeexample, inhibiting glycoprotein synthesis induces CHOP
5-fold more effectively than expressing PLP1msd on course of induction lags behind that of Chop by as much
as 6 days (Figure 2A). Furthermore, Atf3 expression lev-a per cell basis (we routinely obtain 50% transfection
efficiency in 293T cells), and we obtain similar results els decrease earlier than Chop, from approximately P15.
Previously, we demonstrated accumulation of mutantusing COS-7 cells (data not shown). Thus, these data
suggest that UPR activation is a graded response rather DM-20/PLP1 in the perinuclear region of msd and rsh
mouse oligodendrocytes (Gow et al., 1998). We interpretthan an on/off switch.
To confirm the transfection data in Figure 1A, we cul- these data in terms of protein misfolding, which sug-
gests that a common molecular mechanism accountstured oligodendrocyte progenitors from msd mouse
brains and differentiated these cells to induce expres- for the phenotypes of these allelic mutants. In support
of this notion, we find that both Chop and Atf3 are in-sion of Plp1 gene products. Primary transcripts from
this gene are alternatively spliced in exon 3 to encode duced in spinal cords of rsh mice compared to lit-
termates at P21 (Figure 2B) as well as in jp mice. To-two protein isoforms, PLP1 (contains exon 3a and b)
and DM-20 (contains only exon 3a). The smaller DM- gether, these data reveal important similarities in
pathogenesis for all three mouse mutants despite dis-20 protein lacks a 35 amino acid hydrophilic peptide
(encoded by exon 3b) which is near the center of the tinct genetic lesions and disease severities in these an-
imals.protein and is exposed to the cytoplasm (Gow et al.,
1997). Remaining exons are present in both mRNAs. Steady-state mRNA levels of three molecular chaper-
ones in spinal cords of msd, rsh, and jp mice are shownWild-type oligodendrocytes extend processes from the
cell body and incorporate DM-20/PLP1 into the plas- in Figure 2C. In msd mice, mRNAs for Bip, Erp59, and
Erp72 are increased, particularly at P13, when the be-malemma (green, Figure 1Da). These processes elabo-
rate membrane sheets that are also DM-20/PLP1 posi- havioral phenotype becomes apparent. In similar fash-
ion, jp and rsh mice exhibit roughly 2-fold increases intive. The arrowhead points to the nucleus, which is not
labeled by anti-CHOP antibodies. However, nuclei of the levels of molecular chaperones, which again points
to activation of the UPR. Previously, we reported expres-DM-20/PLP1-positive oligodendrocytes from msd mice
are robustly CHOP positive, which appears yellow (ar- sion of six molecular chaperones induced to varying
extents in msd and jp mice, which implies broad induc-rowhead, Figure 1Db), and demonstrates activation of
the UPR. In these cells, DM-20/PLP1 staining is largely tion of this class of stress-induced genes (Southwood
and Gow, 2001). It is likely that relatively modest in-confined to the perinuclear region, which is a common
feature of oligodendrocytes from Plp1 mutant animals creases in expression of molecular chaperones in Figure
2C reflect the low abundance of oligodendrocytes in(Williams and Gard, 1997). Debris surrounding the cell
body marks the locations of cell processes likely re- spinal cord (10% of total cells). Indeed, 5- to 10-fold
increases in expression are apparent in optic nerve (Fig-sorbed as accumulating mutant proteins perturbed cell
function (arrows). ure 2D), in which oligodendrocytes comprise over 50%
of cells.
UPR Induction Correlates with Plp1 Expression
in Mutant Mice Chop Target Genes in the CNS
CHOP is widely believed to play a central role in the UPR,In view of our in vitro data, we examined expression of
the Chop gene in msd mice with age to determine if although this role has not been precisely determined.
Target genes, or Downstream-Of-CHOP (Doc) genes,induction parallels transcription from the Plp1 gene. Ex-
pression of Plp1 in spinal cord is low in the perinatal have been identified using representational difference
analysis from tunicamycin-treated fibroblasts (Wang etperiod, and we detect message on Northern blots begin-
ning at P4 in wild-type mice, with a rapid increase there- al., 1998), which prompted us to examine expression of
these genes in Plp1 mutants. Four Doc genes inducedafter (Figure 2A). Message levels in msd mice are detect-
able by P7 but remain roughly constant beyond this age by CHOP are Chop itself (Doc2); Carbonic Anhydrase
VI (Doc1); a gene encoding the cytoskeleton bindinguntil death. Chop expression in msd mice increases
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Figure 2. Temporal Induction of Chop and
Atf3 in Spinal Cord from Mutant Mice Corre-
lates with Plp1 Expression
(A) Northern blots from wild-type (wt) and
msd mice between P4–P21 express Plp1,
Chop, and Atf3. Ethidium bromide-stained
18S rRNA serves as loading controls.
(B) Northern blots from wild-type (wt), jp, and
rsh mice at P18 and P21 show that Chop and
Atf3 are elevated in the mutants.
(C) Northern blots from msd, jp, and rsh mice
show induction of molecular chaperones.
(D) Northern blots from optic nerve of msd
mice show induction of UPR effector genes.
(E) Northern blots from tunicamycin-treated
3T3 cells (2 g/mL, 4 hr), wild-type, and msd
mice show that Doc genes are not induced
by mutant Plp1 expression.
(F) Doc1 expression cannot be detected by
nonquantitative RT-PCR from wild-type or
msd mice after 35 cycles. Expression of
Docs4 and 6 is detected.
(G) Ribonuclease protection assays show
that Doc4 expression is decreased in msd
mice to 57% of controls.
(H) Northern blots show that Doc4 transcripts
are processed differently in wild-type and
msd mice.
protein, advillin (Doc6); and Doc4, encoding the evolu- postnatal development. The DNA stain DAPI reveals glial
cell nuclei in the white matter (Figure 3C).tionarily conserved teneurin-4 protein. Although ex-
pressed by tunicamycin-treated 3T3 cells (Figure 2E), Disease in msd mice is accompanied by profuse and
widespread oligodendrocyte apoptosis which, by P18,Northern blots demonstrate that these genes are not
induced in msd spinal cord compared with littermates. is at an advanced stage in many CNS regions (Gow et
al., 1998). Few oligodendrocytes remain in cerebellarIndeed, Docs1 and 6 are not detected, and Doc4 mRNA
levels actually decrease in the mutants. By nonquantita- white matter, and DM-20/PLP1 staining is principally
localized to perinuclear regions of these cells (inset,tive RT-PCR, we detect Doc4 and Doc6 but not Doc1
mRNAs, indicating that this latter gene, at least, is not Figures 3D and 3F). Many oligodendrocytes in the cere-
bellum express CHOP at high levels, and, most impor-a target of CHOP in the CNS (Figure 2F).
Quantification of Doc4 levels by ribonuclease protec- tantly, this protein is nuclear localized (inset, Figures 3E
and 3F). Expression and nuclear localization of CHOPtion assays indicate that expression is decreased to
57% of wild-type levels, using -actin as an internal in rsh oligodendrocytes is similar to that in msd mice
(inset, Figures 3H and 3I). Thus, together with our previ-control (Figure 2G). In addition, Northern blots show
that Doc4 transcripts are differentially processed in msd ous findings that DM-20/PLP1 trafficking is disrupted in
msd and rsh oligodendrocytes (Gow et al., 1998), Figurescompared to littermates (Figure 2H). Thus, two forms
of Doc4 mRNA, differing in size by 1–2 kilobases, are 2 and 3 demonstrate similarities in the pathogenesis of
these allelic mutants.apparent in wild-type tissue, while only the larger mes-
sage is present in mutants. The significance of this ob- Brainstem is another heavily myelinated region of
CNS, and DM-20/PLP1 staining in wild-type tissue isservation is currently unclear, and we do not know if
alternative splicing and/or the use of alternate polyade- shown in Figure 4A. ATF3 is not detected in this field
(Figure 4B). In contrast, ATF3-positive oligodendrocytesnylation signals account for the difference. In either
case, Doc4 mRNA processing in response to ER stress are observed in msd and rsh mice (white arrowheads,
Figures 4D and 4E, 4G and 4H), although some oligoden-was not observed in earlier studies (Wang et al., 1998).
drocytes are ATF3 negative (black arrowheads). In addi-
tion, PLP1/DM-20 expression is not detected in some
Oligodendrocytes Express CHOP and ATF3 In Vivo ATF3-positive cells (arrows, Figures 4G–4I).
Induction of the Chop and Atf3 genes in myelin mutant
mice prompted us to identify cells expressing these
transcription factors and to determine if the proteins are Oligodendrocytes and Microglia Express CHOP
and ATF3 in Brains of Mutant Micenuclear localized. Anti-DM-20/PLP1 antibodies strongly
label white matter tracts in the cerebellum of P18–21 Morphometric analyses throughout the brains of three
P18 msd mice indicate that 100% of CHOP-positivewild-type mice (Figure 3A). However, CHOP is not de-
tected in any cells in this field (Figure 3B), commensurate nuclei (n  300 cells) are from DM-20/PLP1-positive
oligodendrocytes (Figure 5). Similarly, counts from twowith a low level of steady-state mRNA during normal
An Unfolded Protein Response in PMD
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Figure 3. CHOP Is Localized to Nuclei of DM-20/PLP1 Oligodendrocytes in P18 Cerebellum from msd and rsh Mice
(A) Immunofluorescence labeling in wild-type mice using anti-DM-20/PLP1 antibodies.
(B) CHOP is not detected in this field.
(C) DAPI stain shows locations of nuclei.
(D) DM-20/PLP1 staining in msd mice is largely perinuclear (arrowheads).
(E and F) Nuclei are stained with anti-CHOP antibodies (arrowheads).
(G) Anti-DM-20/PLP1 antibodies label rsh myelin sheaths in the pons.
(H and I) Oligodendrocyte nuclei are labeled with anti-CHOP antibodies (arrowheads). Inset shows an oligodendrocyte at high magnification
with CHOP in the nucleus (arrowhead). Scale bars, 20 m in (B); inset, 3 m.
rsh mice reveal that 99% of CHOP-positive oligoden- (Hobson et al., 2000). We confirm these data using white
matter mRNA by reverse transcriptase-PCR and se-drocytes express DM-20/PLP1 (n  113). However,
ATF3-positive, DM-20/PLP1-negative cells account for quencing of the amplified products; open reading
frames from the dominant cDNA species encode puta-17% (n 109) in msd and 31% (n  143) in rsh brains.
Colocalization analyses (averages from two mice) using tive proteins of 27.8 kDa (PLP1exon6) and 24 kDa (DM-
20exon6). Furthermore, expression of cloned cDNAs incell-specific markers reveal that Mac-3-positive micro-
glia account for 19%  3.7% and 35% 2.2% of ATF3- our COS-7 cell paradigm (Gow, 2002; Gow and Lazzarini,
1996) causes accumulation of mutant PLP1 and DM-20positive nuclei in msd (n  321) and rsh (n  293),
respectively. On the other hand, we observe 2% colo- in the ER of transfected cells (Figure 6A).
Oligodendrocytes are widely known to be localizedcalization for ATF3 and S100 (astrocytes) and 1% for
ATF3 and Mac-1 (macrophages) or ATF3 and CD3	 (T to white matter tracts (WM); however, these cells also
reside in gray matter (GM), as reflected in Northern blotscells). Thus, the major cell populations that express
ATF3 in CNS of rsh and msd mice are oligodendrocytes of patient tissue probed with human PLP1 cDNA (Figure
6B). In an MS patient, CHOP is expressed at comparableand microglia.
steady-state levels in gray and nonplaque white matter
regions. Gray matter is largely comprised of neuronalThe UPR Is Induced Specifically in White Matter
of a PMD Patient cell bodies, while white matter is rich with glial cells;
thus, different cell types in apparently normal tissueTo determine the relevance to PMD of our conclusions
from previous (Gow et al., 1994b, 1998; Gow and Lazza- express CHOP at low but comparable levels. In contrast,
we observe a 5-fold increase in CHOP between whiterini, 1996; Southwood and Gow, 2001) and current analy-
ses, we examined expression of UPR effector genes in and gray matter from the exon6 patient, indicating that
this gene is selectively induced in the glial cell popula-autopsy specimens from a patient with multiple sclero-
sis (MS) and a PMD patient with severe disease caused tion. Furthermore, ATF3, BIP, ERp59, and ERp72 are
selectively induced in white matter from this patient.by a splice site mutation in intron 6 of the PLP1 gene
that causes an in-frame deletion of the 66 base pair Thus, these data are consistent with our findings in vitro
and in animal models demonstrating activation of theexon 6 (exon6) in mRNAs from cultured skin fibroblasts
Neuron
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Figure 4. ATF3 Is Localized to Nuclei of DM-20/PLP1 Oligodendrocytes in Brainstem from msd and rsh
(A) Immunofluorescence labeling of white matter from wild-type mice using anti-DM-20/PLP1 antibodies.
(B) ATF3 is not detected in this field. Scale bar, 20 m.
(C) DAPI stain shows locations of nuclei.
(D) DM-20/PLP1 staining in msd mice is largely perinuclear (arrowheads).
(E and F) Nuclei in some oligodendrocytes are stained with anti-ATF3 antibodies (white arrowheads); others are unstained (black arrowheads).
(G) Anti-DM-20/PLP1 antibodies label oligodendrocytes (arrowheads) and myelin sheaths in rsh mice.
(H and I) Some cells are labeled with anti-ATF3 antibodies (white arrowheads), while others are ATF3
 (black arrowheads). Arrows show
ATF3, DM-20/PLP1
 cells.
UPR in response to coding region mutations in the PLP1 of PMD. Interestingly, BIP expression in gray matter
gene. Comparable CHOP expression in gray matter of from the MS patient is elevated above white matter;
the MS and exon6 patients suggests that metabolic however, its significance is currently unknown.
stress in neurons is not a significant pathogenic feature
MBP-Positive Oligodendrocytes in a PMD Patient
Localize CHOP to the Nucleus
To determine the identity of CHOP-expressing cells in
white matter from the exon6 patient, we labeled paraf-
fin sections from neocortex with antibodies against my-
elin basic protein (MBP) and CHOP (Figure 6C). MBP
strongly labels myelin membrane around axons (double
arrow, Figure 6Ca) as well as the plasma membrane
of an oligodendrocyte cell body (arrow). This cell also
expresses CHOP in the nucleus (Figure 6Cb), which is
evident from its colocalization with the nuclear stain
DAPI (Figure 6Cc). Three additional cells are weakly
MBP positive and express CHOP in the cytoplasm (ar-
rowheads, inset). Presumably, these cells are at the ini-
tial stage of synthesizing myelin proteins such as MBP
and DM-20/PLP1 and have induced the UPR, although
Figure 5. Oligodendrocytes and Microglia Comprise the CHOP
it appears that nuclear translocation of CHOP has notand ATF3 Cell Populations in Brains of msd and rsh Mice
yet occurred. We are unable to detect DM-20/PLP1 orEssentially all CHOP cells in the CNS of msd and rsh mice are
ATF3 in brain sections from this patient using severaloligodendrocytes. Oligodendrocytes and microglia are the major
cell populations comprising ATF3 cells. antibodies.
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Figure 6. CHOP and ATF3 Are Induced in
White Matter from a PMD Patient Harboring
the exon6 Mutation
(A) Immunofluorescence labeling of mutant
PLP1 (Aa) and DM-20 (Ab) encoded by cDNAs
from a exon6 PMD patient show protein ac-
cumulating in the ER of transfected COS-7
cells. Scale bar, 5 m.
(B) Northern blot of white matter (WM) and
gray matter (GM) from a multiple sclerosis
patient (MS) and a exon6 PMD patient. 18S
serves as loading controls.
(C) An oligodendrocyte (arrow) labeled with
anti-MBP antibodies (Ca) expresses CHOP
(Cb) in the nucleus (Cc). Three additional oli-
godendrocytes (arrowheads and inset) ex-
press CHOP in the cytoplasm. Scale bar,
5 m.
CHOP Modulates Disease Severity in rsh Mice Experimental Procedures for husbandry details). Wild-
type and Chop null mice, which have no known pheno-The data presented in Figures 1–5 suggest a role for
CHOP in pathogenesis associated with coding region type, live beyond 20 weeks of age. Similarly, rsh mice
exhibit normal longevity, as shown previously (Schnei-mutations in the PLP1 gene. Early in vivo experiments
demonstrate that epithelial cells in the kidneys of mice der et al., 1992). In dramatic contrast, disease in Chop
null/rsh mice is substantially more severe than that con-undergo CHOP-dependent apoptosis with a predictable
time course after acute tunicamycin toxicity (Wang et ferred by the rsh mutation alone, and double mutants
exhibit frequent seizures induced by sudden noise, han-al., 1998).
To determine if CHOP modulates pathogenesis asso- dling, or startle responses. These mice die as early as
5 weeks of age and have an average life span of lessciated with Plp1 mutations, we crossed Chop null mice
(Zinszner et al., 1998) with rsh mice to generate Chop than 10 weeks. Despite apparent longevity, rsh mice that
harbor a single functional Chop gene exhibit occasionalnull/rsh double mutants. A Kaplan-Meier analysis of
these mice is shown in Figure 7, where the ordinate seizures, consistent with an intermediate phenotype
stemming from haplo-insufficiency at the Chop locus.indicates the number of mice for each genotype (see
Figure 7. Kaplan-Meier Analysis and Oligo-
dendrocyte Apoptosis in Chop Null/rsh Mice
(A) Survival over 20 weeks in sib cohorts of
wild-type, rsh, Chop null, Chop null/rsh, and
Chop-het/rsh mice. The ordinate indicates
the number of mice in each cohort.
(B) Levels of apoptosis are 5-fold higher in
cervical spinal cord from P16 msd mice com-
pared to controls.
(C) Electron micrographs show (Ca) a mor-
phologically normal oligodendrocyte from a
Chop null mouse surrounded by myelinated
fibers and (Cb) an apoptotic oligodendrocyte
from a Chop null/rsh mouse with condensed
chromatin (arrowhead) surrounded by large
unmyelinated axons (asterisks). Scale bar,
1 m.
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Together, these data provide direct evidence for a piv- be related to the cell type-specific target genes of this
transcription factor. Nevertheless, available data con-otal role of CHOP in pathogenesis and demonstrate
vincingly indicates that CHOP is a key regulatory com-that the activity of this transcription factor serves to
ponent of the UPR in kidney cells and oligodendrocytes.ameliorate the toxic effects of mutant DM-20/PLP1 in
Additional diversity in cell type-specific functions ofoligodendrocytes.
Chop is revealed in a recent examination of diabetic
Akita mice. This mouse harbors a C96Y missense muta-Oligodendrocyte Apoptosis in Chop Null/rsh Mice
tion in the Insulin2 gene, and a single mutant allele leadsIn a hunt for cellular mechanisms that account for high
to hyperglycemia in the first month of life (Oyadomarimortality in Chop null/rsh mice, we examined levels of
et al., 2002). Interestingly, hyperglycemia develops at aapoptosis in CNS, which are elevated for Plp1 mutants
slightly later age in the absence of the Chop gene (i.e.,with severe forms of disease (Schneider et al., 1992). At
Ins2WT/C96Y, Chop null mice), and pancreatic  cells un-early postnatal ages, the number of TUNEL-positive
dergo cell death with reduced frequency. On the othercells in cervical spinal cord from Chop null/rsh mice is
hand, apoptosis of  cells in Akita mice with two mutantelevated5-fold over age-matched controls (Figure 7B),
Insulin2 alleles is equally widespread in the presence orand by 10 weeks, apoptotic oligodendrocytes are wide-
absence of CHOP. These data indicate that Chop is notspread in optic nerve and spinal cord from double mu-
required for pancreatic  cell death in the context of thetants. A morphologically normal oligodendrocyte sur-
UPR, similar to oligodendrocytes. Nonetheless, CHOProunded by myelinated axons (arrows) in optic nerve
in  cells exhibits weak proapoptotic properties whichfrom a Chop null mouse is shown in Figure 7Ca. On
contrast with its strong prosurvival role in oligodendro-the other hand, many oligodendrocytes in Chop null/rsh
cytes from rsh mice.mice have abnormally shaped nuclei and exhibit regions
In support of cell type-specific functions for CHOP,of condensed chromatin around the nuclear membrane
we find that target genes in oligodendrocytes overlap(arrowhead, Figure 7Cb). Moreover, oligodendrocyte
with but are distinct from those in other cell types. Thus,loss and dysfunction is evident from the large number of
Chop induction in msd mice does not induce expressionunmyelinated axons in these mutants (asterisks). Thus,
of Docs 1, 4, and 6, in contrast to mouse embryonicthese data demonstrate that CHOP plays a critical role
fibroblasts treated with tunicamycin (Wang et al., 1998).in protecting oligodendrocytes from the detrimental
The molecular basis underlying this cell-specific targetconsequences of unfolded proteins in the ER and are
gene selection is currently unknown, but a likely possibil-consistent with the correlation between oligodendro-
ity is the partnering of CHOP with oligodendrocyte-spe-cyte death and shortened life span of PLP1 mutants
cific bZip transcription factors. Nevertheless, we cannotwith severe forms of disease, such as msd and jp mice.
exclude the prospect that target gene selection arises
from unique aspects of UPR induction, such as acuteDiscussion
tunicamycin exposure versus persistent PLP1 gene ex-
pression.Although several features of the UPR are well-character-
A second feature of the UPR to emerge from this study
ized, a rapid expansion in our understanding of this
is that CHOP expression (and ATF3) is not a prelude to
signaling cascade has occurred only since identification
programmed cell death under all conditions, an impor-
of the upstream initiating elements of the pathway—
tant divergence that dramatically alters the life span of
such as ATF6, Ire1, and PERK—as well as molecular and disease severity in Plp1 mutant mice. In msd and
chaperones and transcription factors, which effect jp mice, oligodendrocyte apoptosis is widespread in the
changes in gene expression upon UPR activation. In this CNS (Gow et al., 1998) and depletes this cell lineage
study, we examine expression of two effector proteins, shortly before the animals die (Knapp et al., 1986). On
CHOP and ATF3, in PMD brain as well as animal models, the other hand, oligodendrocyte populations in white
and find them to be nuclear localized in oligodendro- matter tracts of rsh mice are slightly expanded com-
cytes expressing mutant PLP1 gene products. Further- pared to controls (Fanarraga et al., 1992), which may
more, we show induction of several molecular chaper- reflect compensation to overcome diminished myelin
ones. Finally, we demonstrate direct involvement of synthesis and/or reduced numbers of axons ensheathed
CHOP in the pathogenesis of PMD and reveal novel and per cell. These data suggest common features of patho-
important features of the UPR in oligodendrocytes, as genesis in rsh, msd, and jp mice, despite substantial
indicated below. differences in life span. Thus, activation of the UPR per
First, CHOP does not serve identical functions in oligo- se does not govern oligodendrocyte survival or disease
dendrocytes to those demonstrated in fibroblasts and severity, which must be regulated by additional factors
kidney proximal tubule epithelial cells. For example, (Gow and Lazzarini, 1996).
DNA condensation and fragmentation in kidney cells Third, UPR activation appears to be limited to genetic
from tunicamycin-treated Chop null mice are not promi- forms of PMD causing coding region mutations in PLP1.
nent features of pathology, in stark contrast to control For example, immunocytochemical analyses of brain
animals. Thus, CHOP is required for apoptosis of these and spinal cord from 4e-Plp mice, which overexpress a
cells (Zinszner et al., 1998). However, oligodendrocytes wild-type Plp1 transgene in oligodendrocytes (Kagawa
in optic nerve and spinal cord from Chop null/rsh mice et al., 1994), indicate that the UPR is not induced; indeed,
undergo apoptosis with greater frequency than in con- we are unable to detect expression of either CHOP or
trols (Figure 7). These data reveal a major divergence ATF3 in oligodendrocytes from these mutants. Further-
in importance of CHOP as a central mediator of cell more, expression of these transcription factors is not
induced in white matter from a PMD patient harboringdeath for different cell types which, conceivably, could
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of misfolded protein in this organelle (Gow and Lazzarini,
1996). Finally, we show in Figure 1C that, on a per cell
basis, the glycoprotein synthesis inhibitor tunicamycin
induces Chop expression far more effectively than does
PLPmsd, although Atf3 and BiP are induced with similar
efficiencies.
Other studies provide evidence of variable disease
severity that is consistent with a graded UPR. When
expressed in oligodendrocytes of transgenic mice, the
H-2Kb MHC protein accumulates in the ER and causes
hypomyelination above a threshold of transgene expres-
sion (Baerwald et al., 2000; Power et al., 1996; Turnley
et al., 1991). This threshold can be breached in hemizy-
gotes by high-level transgene expression or by mating
two asymptomatic lines. Moreover, expression signifi-
cantly above this threshold also decreases life span to
3 weeks and causes widespread, nonimmune-mediatedFigure 8. Possible Models to Account for the Correlation between
oligodendrocyte apoptosis. In analogous experiments,Disease Severity in PMD and DM-20/PLP1 Trafficking Defects
high-level expression of H-2Kb in pancreas causes wide-(A) UPR portrayed as a graded response that is proportional to the
spread apoptosis of  cells and diabetes, again by alevel of misfolded protein in the ER; the higher the level, the stronger
the UPR. (Aa) Mutations causing ER accumulation of both PLP1 and nonimmune mechanism (Allison et al., 1988). Presum-
DM-20 induce a strong UPR. (Ab) Mutations causing accumulation of ably, these cells are particularly sensitive to overwhelm-
PLP1 but not DM-20 induce a weak response. ing the ER or disrupting the UPR, because knockout
(B) UPR portrayed as an off/on switch upon misfolded protein accu- mice that lack the gene encoding the UPR initiator re-
mulation. (Ba) PLP1 and DM-20 accumulation induces the UPR.
ceptor kinase PERK also exhibit high levels of  cellDM-20 is toxic and disrupts cell survival pathways (?). (Bb) Accumu-
death and diabetes (Harding et al., 2001).lation of only PLP1 in the ER induces the UPR but does not affect
Despite considerable precedence for graded UPR sig-cell survival pathways.
naling, we cannot formally exclude the possibility that
severe forms of PMD result specifically from disruptinga PLP1 duplication (data not shown). Morphological evi-
DM-20 trafficking (Figure 8B). For example, rsh and msddence also distinguishes disease caused by coding re-
mutations may activate the UPR in oligodendrocytes togion mutations versus overexpression. In transgenic
similar extents; however, accumulation of DM-20 in themice overexpressing Plp1, the major ultrastructural de-
ER of msd oligodendrocytes may activate additionalfect observed in oligodendrocytes is distention of Golgi
pathways (“?” in Figure 8Ba) that block survival mecha-cisternae (Kagawa et al., 1994; Readhead et al., 1994),
nisms normally regulated by the UPR. Alternatively, ac-while Plp1 coding region mutations distend the ER (Dun-
cumulation of mutant DM-20 in the ER but not mutant
can, 1990). In accord with these ultrastructural changes,
PLP1 may be particularly toxic to cells.
we anticipate a UPR associated with the latter but not
Recent appreciation of the UPR has led to speculation
the former genetic form of PMD. However, perhaps the
that disrupting or overwhelming this signaling cascade
strongest evidence of a distinct pathogenic mechanism might play a role in pathogenesis for a number of degen-
for Plp1 overexpression is revealed by a recent study erative diseases (Aridor and Balch, 1999). Herein, we
showing inappropriate targeting to lysosomes of choles- show that PLP1 mutations induce the UPR and that
terol and lipid raft components, which are normally disruption of this pathway dramatically increases dis-
sorted to the Golgi (Simons et al., 2002). ease severity. Thus, PMD is the first example of a degen-
Consistent with variable disease severity observed for erative disease where the UPR modulates pathogenesis.
different PLP1 coding region mutations, we speculate In the search for additional UPR-linked diseases, it is
that upstream elements of the UPR confer a graded important to develop criteria that exclude diseases aris-
response to metabolic stress: the greater the accumula- ing from other pathogenic mechanisms. In this vein, null
tion, the more intense the UPR and the higher the likeli- alleles should confer a phenotype that is significantly
hood of apoptosis. Several studies support this model. more mild than or clinically distinct from at least some
For example, we previously described a cellular mecha- coding region mutations. This criterion rules out muta-
nism that accounts for disease severity in PMD on the tions that simply abolish protein function. This is the
basis of the amount of PLP1 gene products accumulat- case for PLP1 and for 1-ANTITRYPSIN, where null mu-
ing in the ER (Gow and Lazzarini, 1996). The interpreta- tations cause emphysema and missense mutations ac-
tion from these data and additional mutations (A.G., cumulating in the ER cause hepatitis (Dycaico et al.,
unpublished data) is illustrated in Figure 8A. Thus, eight 1988).
missense mutations causing ER accumulation of both A second distinguishing feature of UPR-linked dis-
DM-20 and PLP1 (including msd) give rise to severe eases is dominant or semidominant inheritance, at least
disease (Figure 8Aa). In contrast, nine mutations that at the level of individual cells. PMD is technically a reces-
disrupt trafficking to the cell surface of PLP1 but not sive disease, because PLP1 is located on the X chromo-
DM-20 (including rsh) cause mild disease (Figure 8Ab). some, and carrier females rarely develop symptoms.
Furthermore, wild-type or mutant forms of DM-20 that However, mutant PLP1 gene products act dominantly
traverse the secretory pathway can transport mutant because the jp phenotype cannot be rescued with a
wild-type Plp1 transgene (Schneider et al., 1995). Addi-PLP1 out of the ER, which, presumably, reduces levels
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with 2% paraformaldehyde and labeled with anti-ATF3 antibodies.tional features for this class of diseases require in vivo
Secondary antibodies were from Vector Labs (Burlingame, CA) andand in vitro expression studies to determine if mutant
Southern Biotech (Birmingham, AL). TUNEL labeling was carried outgenes encode secretory pathway proteins that accumu-
on 10 m transverse spinal cord cryostat sections (Gow et al., 1998).
late in the ER. Thus, protein aggregation is a prominent
feature of trinucleotide repeat diseases such as Hunting- Kaplan-Meier Analysis
ton disease, but this aggregation often occurs in the This analysis was carried out in three concurrent phases. First, Chop
null male mice (Zinszner et al., 1998) with a wild-type Plp1 genenucleus and would not be expected to induce the UPR.
(i.e., Chop
/
, X/Y ) on a mixed B6C3H F1 (Taconic Farms, NY) / 129
Sv/SW background were mated to rsh carrier female mice (i.e.,Experimental Procedures
Chop/, rsh/X ) on a B6C3H F1 (Taconic Farms) background (gift
from Dr. S. Billings-Gagliardi, University of Massachusetts, MA),Primary Oligodendrocyte Cultures and Transfected Cells
then to the Chop/
, rsh/X progeny to generate Chop
/
, rsh/X carrierBrains from P2 male pups were dissociated by trituration through
females. These double mutants were sib mated to Chop
/
, X/Y18G, 21G, and 25G needles in HEPES-buffered MEM (Life Technolo-
mice, and male progeny with genotypes of either Chop
/
, X/Y (Chopgies), pelleted, and plated onto poly-ornithine-coated T25 flasks in
null) or Chop
/
, rsh/Y (Chop null/rsh) were generated with equalhigh-glucose DMEM containing 15% FCS (Hyclone), 1 mM pyruvate,
frequency from ten litters for analysis. Second, Chop
/
, rsh/X carrier1.5 g/l glucose, and Pen-Strep (Life Technologies). Cultures were
females were mated with wild-type hybrid mice to generate Chop/
,grown at 37C for 2 weeks, with media changes every 2–3 days.
rsh/Y mice from one litter for analysis (Chop-het/rsh). Third, Chop/
,Oligodendrocyte progenitors were recovered by light trypsin diges-
rsh/X females were sib mated with Chop/
, X/Y males to recovertion (ATV trypsin, Irvine Scientific, CA) and differentiated at low
the rsh allele on a Chop/ background. Female Chop/, rsh/Xdensity on coated plastic 35 mm dishes (Nunclon) in high-glucose
carriers were sib mated with Chop/, X/Y males to generate maleDMEM containing 2% FCS, pyruvate, glucose, and antibiotics.
wild-type and rsh sib cohorts from six litters for analysis. CohortscDNAs encoding wild-type and mutant DM-20/PLP1 were ex-
of Chop null and Chop null/rsh or Wild-Type and rsh mice comprisepressed for 1–2 days using pCMV5 (Lorence et al., 1990) in FUGENE-
multiple sets of sibs housed in open cages. A nonparametric ANOVA6-transfected COS-7 or 293T cells (Gow, 2002).
(Kruskal-Wallis test) of Chop null/rsh mice revealed no statistical
differences in average life span between individual litters (p  0.36).Autopsy Specimens from PMD and MS Patients
Gray and white matter regions were dissected from the cortex of
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